2015 Q3 Form 10-Q Financial Statement
#000119312515282127 Filed on August 07, 2015
Income Statement
| Concept | 2015 Q3 | 2014 Q4 | 2014 Q2 |
|---|---|---|---|
| Revenue | $494.7M | $583.9M | $481.8M |
| YoY Change | 0.32% | 3.26% | 6.8% |
| Cost Of Revenue | $208.7M | $233.1M | $201.9M |
| YoY Change | 3.21% | 1.8% | 7.18% |
| Gross Profit | $286.0M | $350.8M | $279.9M |
| YoY Change | -1.69% | 4.25% | 6.53% |
| Gross Profit Margin | 57.81% | 60.07% | 58.1% |
| Selling, General & Admin | $122.7M | $131.9M | $131.9M |
| YoY Change | 0.36% | 0.95% | 7.21% |
| % of Gross Profit | 42.88% | 37.61% | 47.13% |
| Research & Development | $30.56M | $28.72M | $26.98M |
| YoY Change | 12.01% | 6.48% | 9.44% |
| % of Gross Profit | 10.68% | 8.19% | 9.64% |
| Depreciation & Amortization | $22.70M | $23.60M | $20.80M |
| YoY Change | -23.05% | 9.77% | 7.22% |
| % of Gross Profit | 7.94% | 6.73% | 7.43% |
| Operating Expenses | $153.2M | $160.6M | $158.9M |
| YoY Change | 2.48% | 1.89% | 7.58% |
| Operating Profit | $130.3M | $172.0M | $118.4M |
| YoY Change | -6.05% | -2.35% | 5.06% |
| Interest Expense | $9.046M | $9.669M | $7.971M |
| YoY Change | -0.18% | 21.98% | 5.16% |
| % of Operating Profit | 6.94% | 5.62% | 6.73% |
| Other Income/Expense, Net | $0.00 | ||
| YoY Change | |||
| Pretax Income | $123.8M | $164.5M | $112.1M |
| YoY Change | -5.81% | -2.87% | 7.07% |
| Income Tax | $18.12M | $13.18M | $15.60M |
| % Of Pretax Income | 14.64% | 8.01% | 13.91% |
| Net Earnings | $105.7M | $151.3M | $96.50M |
| YoY Change | -6.87% | 6.85% | 8.06% |
| Net Earnings / Revenue | 21.36% | 25.91% | 20.03% |
| Basic Earnings Per Share | $1.28 | $1.82 | $1.14 |
| Diluted Earnings Per Share | $1.27 | $1.80 | $1.13 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 82.56M shares | 83.22M shares | 84.46M shares |
| Diluted Shares Outstanding | 83.33M shares | 84.02M shares | 85.18M shares |
Balance Sheet
| Concept | 2015 Q3 | 2014 Q4 | 2014 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $2.209B | $2.055B | $1.918B |
| YoY Change | 13.49% | 13.95% | 16.24% |
| Cash & Equivalents | $365.9M | $422.2M | $428.7M |
| Short-Term Investments | $1.843B | $1.633B | $1.489B |
| Other Short-Term Assets | $118.5M | $118.3M | $88.40M |
| YoY Change | 30.56% | 50.13% | 1.97% |
| Inventory | $272.9M | $246.4M | $272.8M |
| Prepaid Expenses | |||
| Receivables | $406.6M | $433.6M | $401.9M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $3.007B | $2.854B | $2.681B |
| YoY Change | 11.39% | 11.64% | 14.35% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $324.9M | $321.6M | $328.6M |
| YoY Change | 0.62% | -1.03% | 11.11% |
| Goodwill | $353.3M | $354.8M | |
| YoY Change | 1.28% | ||
| Intangibles | $223.2M | $232.4M | |
| YoY Change | -2.82% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $120.5M | $115.4M | $127.2M |
| YoY Change | -6.74% | 3.06% | 14.76% |
| Total Long-Term Assets | $1.022B | $1.024B | $1.047B |
| YoY Change | -2.89% | -0.21% | 11.22% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.007B | $2.854B | $2.681B |
| Total Long-Term Assets | $1.022B | $1.024B | $1.047B |
| Total Assets | $4.029B | $3.878B | $3.728B |
| YoY Change | 7.39% | 8.24% | 13.45% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $65.00M | $65.70M | $65.10M |
| YoY Change | 7.79% | 1.14% | 15.49% |
| Accrued Expenses | $37.50M | $60.50M | $43.10M |
| YoY Change | -20.21% | 7.46% | 11.66% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $175.3M | $225.2M | $233.4M |
| YoY Change | -22.09% | 68.94% | 75.62% |
| Total Short-Term Liabilities | $546.7M | $581.6M | $594.6M |
| YoY Change | -4.84% | 19.29% | 25.19% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $1.385B | $1.240B | $1.160B |
| YoY Change | 14.94% | 4.2% | 2.2% |
| Other Long-Term Liabilities | $61.01M | $56.05M | $106.0M |
| YoY Change | -43.66% | 34.19% | 231.07% |
| Total Long-Term Liabilities | $1.550B | $1.402B | $1.266B |
| YoY Change | 17.99% | 5.24% | -1.9% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $546.7M | $581.6M | $594.6M |
| Total Long-Term Liabilities | $1.550B | $1.402B | $1.266B |
| Total Liabilities | $2.096B | $1.983B | $1.884B |
| YoY Change | 9.76% | 9.0% | 6.72% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $4.596B | $4.395B | |
| YoY Change | 10.89% | ||
| Common Stock | $1.441B | $1.394B | |
| YoY Change | 9.58% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $3.986B | $3.815B | |
| YoY Change | 9.7% | ||
| Treasury Stock Shares | 73.57M shares | ||
| Shareholders Equity | $1.933B | $1.895B | $1.844B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $4.029B | $3.878B | $3.728B |
| YoY Change | 7.39% | 8.24% | 13.45% |
Cashflow Statement
| Concept | 2015 Q3 | 2014 Q4 | 2014 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $105.7M | $151.3M | $96.50M |
| YoY Change | -6.87% | 6.85% | 8.06% |
| Depreciation, Depletion And Amortization | $22.70M | $23.60M | $20.80M |
| YoY Change | -23.05% | 9.77% | 7.22% |
| Cash From Operating Activities | $112.9M | $161.7M | $106.3M |
| YoY Change | -11.66% | 12.84% | -2.48% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$23.90M | -$34.00M | -$22.80M |
| YoY Change | -14.64% | 32.3% | -25.73% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$184.2M | -$45.60M | -$31.00M |
| YoY Change | 52.74% | -58.43% | -59.69% |
| Cash From Investing Activities | -$208.1M | -$79.60M | -$53.90M |
| YoY Change | 40.04% | -41.17% | -49.86% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 11.70M | -2.400M | -25.40M |
| YoY Change | -129.92% | -4.0% | 37.3% |
| NET CHANGE | |||
| Cash From Operating Activities | 112.9M | 161.7M | 106.3M |
| Cash From Investing Activities | -208.1M | -79.60M | -53.90M |
| Cash From Financing Activities | 11.70M | -2.400M | -25.40M |
| Net Change In Cash | -83.50M | 79.70M | 27.00M |
| YoY Change | 39.4% | 1349.09% | -258.82% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $112.9M | $161.7M | $106.3M |
| Capital Expenditures | -$23.90M | -$34.00M | -$22.80M |
| Free Cash Flow | $136.8M | $195.7M | $129.1M |
| YoY Change | -12.2% | 15.8% | -7.59% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
28.17 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
22.38 | ||
| CY2015Q3 | us-gaap |
Assets
Assets
|
4028844000 | USD |
| CY2015Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
156716000 | shares |
| CY2015Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2015Q3 | wat |
Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
|
7451000 | USD |
| CY2015Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2015Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | wat |
Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
|
7179000 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2015Q3 | us-gaap |
Liabilities
Liabilities
|
2096246000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
| CY2015Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
157193000 | shares |
| CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
354838000 | USD |
| CY2015Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
120491000 | USD |
| CY2015Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
406583000 | USD |
| CY2015Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
83147000 | shares |
| CY2015Q3 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.146 | pure |
| CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
123772000 | USD |
| CY2015Q3 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
162704000 | USD |
| CY2015Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
122660000 | USD |
| CY2015Q3 | us-gaap |
Inventory Net
InventoryNet
|
272932000 | USD |
| CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
115406000 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2853736000 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
3877934000 | USD |
| CY2014Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
232371000 | USD |
| CY2015Q3 | us-gaap |
Assets Current
AssetsCurrent
|
3006957000 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
321583000 | USD |
| CY2015Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
118549000 | USD |
| CY2015Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
1549552000 | USD |
| CY2015Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
324896000 | USD |
| CY2015Q3 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
2209000000 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.139 | pure |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
2800000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-10791000 | USD | |
| us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (“Waters</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” or the “Company”) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an analytical instrument manufacturer</font><font style="font-family:Times New Roman;font-size:10pt;"> that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) </font><font style="font-family:Times New Roman;font-size:10pt;">technology </font><font style="font-family:Times New Roman;font-size:10pt;">systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed </font><font style="font-family:Times New Roman;font-size:10pt;">together</font><font style="font-family:Times New Roman;font-size:10pt;"> (“LC-MS”)</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">sold as integrated instrument systems using a common software platform</font><font style="font-family:Times New Roman;font-size:10pt;">. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease process</font><font style="font-family:Times New Roman;font-size:10pt;">es (known as “proteomics”), nutritional</font><font style="font-family:Times New Roman;font-size:10pt;"> safety analysis and environmental testing. LC</font><font style="font-family:Times New Roman;font-size:10pt;">-MS</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine </font><font style="font-family:Times New Roman;font-size:10pt;">a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (“TA</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">”), the Company primarily designs, manufactures, sells and services thermal analysis, </font><font style="font-family:Times New Roman;font-size:10pt;">rheometry</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">calorimetry</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments, which are used in predicting the suitability </font><font style="font-family:Times New Roman;font-size:10pt;">and stability </font><font style="font-family:Times New Roman;font-size:10pt;">of fine chemicals,</font><font style="font-family:Times New Roman;font-size:10pt;"> pharmaceuticals, water,</font><font style="font-family:Times New Roman;font-size:10pt;"> polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments</font><font style="font-family:Times New Roman;font-size:10pt;">, as well as other </font><font style="font-family:Times New Roman;font-size:10pt;">suppliers' </font><font style="font-family:Times New Roman;font-size:10pt;">instruments,</font><font style="font-family:Times New Roman;font-size:10pt;"> and are typically purchased by customers as part of the instrument system.</font></p> | ||
| CY2015Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
223160000 | USD |
| CY2015Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
365875000 | USD |
| CY2014Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
85230000 | USD |
| CY2015Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
61014000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
581595000 | USD |
| CY2015Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
3986161000 | USD |
| CY2014Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
15143000 | USD |
| CY2015Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-118273000 | USD |
| CY2015Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2015Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4028844000 | USD |
| CY2014Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
13266000 | USD |
| CY2014Q4 | us-gaap |
Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
|
129706000 | USD |
| CY2015Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1439229000 | USD |
| CY2015Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
1572000 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
422177000 | USD |
| CY2015Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
4596231000 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
65704000 | USD |
| CY2014Q4 | us-gaap |
Debt Current
DebtCurrent
|
225243000 | USD |
| CY2014Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
85335000 | USD |
| CY2014Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
433616000 | USD |
| CY2014Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1240000000 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
246430000 | USD |
| CY2015Q3 | us-gaap |
Goodwill
Goodwill
|
353340000 | USD |
| CY2014Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
118302000 | USD |
| CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
47198000 | USD |
| CY2015Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1932598000 | USD |
| CY2015Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
105657000 | USD |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
85177000 | shares |
| CY2015Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
82564000 | shares |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
84462000 | shares |
| CY2015Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
83332000 | shares |
| us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-743000 | USD | |
| CY2014Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
84952000 | USD |
| CY2015Q3 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
2500000 | USD |
| CY2015Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
494740000 | USD |
| CY2015Q3 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
332036000 | USD |
| CY2015Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015Q3 | us-gaap |
Gross Profit
GrossProfit
|
286033000 | USD |
| CY2015Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.27 | |
| CY2015Q3 | us-gaap |
Interest Expense
InterestExpense
|
9046000 | USD |
| CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.13 | |
| CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
130318000 | USD |
| CY2014Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
2055000000 | USD |
| CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.28 | |
| CY2015Q3 | us-gaap |
Short Term Investments
ShortTermInvestments
|
1843018000 | USD |
| CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.14 | |
| CY2014Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
73569000 | shares |
| CY2015Q3 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
20419000 | USD |
| CY2014Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
20397000 | USD |
| wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-805000 | USD | |
| wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
62000 | USD | |
| CY2014Q2 | wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-76000 | USD |
| CY2014Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
144729000 | USD |
| CY2014Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
16749000 | USD |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
542000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
13305000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
222087000 | USD | |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
2341000 | USD | |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
2200000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
16610000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-13501000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
29878000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
9596000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
9397000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-22287000 | USD | |
| us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
45293000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-264508000 | USD | |
| us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
195073000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
100019000 | USD | |
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
24777000 | USD | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
170958000 | USD | |
| us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
5689000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-48552000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-56302000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-65673000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-173761000 | USD | |
| us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
44151000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-5727000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-13750000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
267549000 | USD | |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1511000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
16353000 | USD | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-7912000 | USD | |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
440796000 | USD |
| us-gaap |
Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
|
43352000 | USD | |
| us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
8871000 | USD | |
| CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
428691000 | USD |
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
1328292000 | USD | |
| us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
1118485000 | USD | |
| us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
1052736000 | USD | |
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
1178731000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
5242000 | USD | |
| us-gaap |
Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
805000 | USD | |
| us-gaap |
Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
100000 | USD | |
| CY2015Q3 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
11000000 | USD |
| CY2014Q2 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
12000000 | USD |
| us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
22000000 | USD | |
| us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
24000000 | USD | |
| us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
22372000 | USD | |
| us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
23800000 | USD | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
3615000 | USD | |
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
2309000 | USD | |
| us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
4093000 | USD | |
| us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-1057000 | USD | |
| CY2014Q4 | wat |
Cash Equivalents And Investments Gross Unrealized Gains
CashEquivalentsAndInvestmentsGrossUnrealizedGains
|
441000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Gross Unrealized Losses
CashEquivalentsAndInvestmentsGrossUnrealizedLosses
|
-845000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Fair Value
CashEquivalentsAndInvestmentsFairValue
|
1700262000 | USD |
| CY2015Q3 | wat |
Debt Securities
DebtSecurities
|
1806220000 | USD |
| CY2014Q4 | wat |
Debt Securities
DebtSecurities
|
1635875000 | USD |
| CY2015Q3 | wat |
Cash Equivalents And Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
|
956322000 | USD |
| CY2015Q3 | wat |
Cash Equivalents And Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
849898000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
|
872872000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
763003000 | USD |
| us-gaap |
Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
|
Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, while investments with longer maturities are classified as investments. | ||
| CY2015Q3 | wat |
Waters Restoration Plan Assets
WatersRestorationPlanAssets
|
35908000 | USD |
| CY2015Q3 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
1949712000 | USD |
| CY2015Q3 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
4562000 | USD |
| CY2015Q3 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
28999000 | USD |
| us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
4000000 | USD | |
| CY2014Q2 | us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
4000000 | USD |
| CY2015Q3 | us-gaap |
Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
|
4000000 | USD |
| CY2015Q3 | us-gaap |
Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
|
149000 | USD |
| CY2015Q3 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
614000 | USD |
| CY2015Q3 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
3948000 | USD |
| CY2014Q4 | us-gaap |
Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
|
4000000 | USD |
| CY2014Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
1763320000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
4263000 | USD |
| CY2014Q4 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
29000000 | USD |
| CY2014Q4 | us-gaap |
Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
|
123000 | USD |
| CY2014Q4 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
651000 | USD |
| CY2014Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
3612000 | USD |
| CY2015Q3 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
567405000 | USD |
| CY2014Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
574114000 | USD |
| CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
344245000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
341743000 | USD |
| wat |
Intangible Assets Gross Foreign Currency Translation Adjustments
IntangibleAssetsGrossForeignCurrencyTranslationAdjustments
|
-33000000 | USD | |
| wat |
Intangible Assets Accumulated Amortization Foreign Currency Translation Adjustments
IntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationAdjustments
|
-19000000 | USD | |
| CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
44000000 | USD |
| CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
44000000 | USD |
| CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
44000000 | USD |
| CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
44000000 | USD |
| CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
44000000 | USD |
| us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P8Y | ||
| CY2014 | us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P8Y | |
| us-gaap |
Goodwill Translation Adjustments
GoodwillTranslationAdjustments
|
-3000000 | USD | |
| CY2015Q3 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
1560297000 | USD |
| CY2014Q4 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
1465243000 | USD |
| CY2014Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
19596000 | USD |
| wat |
Other Changes In Uncertain Tax Benefits
OtherChangesInUncertainTaxBenefits
|
57000 | USD | |
| wat |
Other Changes In Uncertain Tax Benefits
OtherChangesInUncertainTaxBenefits
|
-1952000 | USD | |
| CY2015Q3 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
-5000000 | USD |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16353000 | USD | |
| CY2015Q3 | wat |
Derivative Notional Amount1
DerivativeNotionalAmount1
|
112000000 | USD |
| CY2014Q4 | wat |
Derivative Notional Amount1
DerivativeNotionalAmount1
|
110000000 | USD |
| CY2014Q2 | us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
138000 | USD |
| CY2014Q2 | wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
214000 | USD |
| wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-100000 | USD | |
| wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-957000 | USD | |
| us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
3230000 | USD | |
| us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-3717000 | USD | |
| CY2013Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
12962000 | USD |
| CY2015Q3 | wat |
Cash Equivalents And Investments Amortized Cost Basis
CashEquivalentsAndInvestmentsAmortizedCostBasis
|
1884477000 | USD |
| CY2015Q3 | wat |
Cash Equivalents And Investments Gross Unrealized Gains
CashEquivalentsAndInvestmentsGrossUnrealizedGains
|
1049000 | USD |
| CY2015Q3 | wat |
Cash Equivalents And Investments Gross Unrealized Losses
CashEquivalentsAndInvestmentsGrossUnrealizedLosses
|
-870000 | USD |
| CY2015Q3 | wat |
Cash Equivalents And Investments Fair Value
CashEquivalentsAndInvestmentsFairValue
|
1884656000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Amortized Cost Basis
CashEquivalentsAndInvestmentsAmortizedCostBasis
|
1700666000 | USD |
| CY2015Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2949000 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
600000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
116.65 | ||
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
99.22 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16610000 | USD | |
| CY2015Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8155000 | USD |
| CY2014Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8224000 | USD |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
37000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
32000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.017 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.019 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.262 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.245 | pure | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | ||
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-296000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-72000 | shares | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
82.85 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
83.25 | ||
| CY2015Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
84.12 | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
74.33 | ||
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3280000 | shares |
| CY2015Q3 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
768000 | shares |
| CY2015Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
500000 | shares |
| CY2014Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
600000 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
600000 | shares | |
| CY2015Q3 | wat |
Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
|
-0.01 | |
| CY2014Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
715000 | shares |
| CY2014Q2 | wat |
Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
|
-0.01 | |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
753000 | shares | |
| wat |
Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
|
-0.03 | ||
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
807000 | shares | |
| wat |
Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
|
-0.02 | ||
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | pure | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | pure |
